Technical Analysis for CDMO - Avid Bioservices, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 10.63 | 0.66% | 0.07 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Flat | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 50 DMA | Bearish | 0.66% | |
| Stochastic Reached Oversold | Weakness | 0.66% | |
| Down 3 Days in a Row | Weakness | 0.66% | |
| Oversold Stochastic | Weakness | 0.66% | |
| Fell Below 20 DMA | Bearish | -1.02% | |
| Wide Bands | Range Expansion | -1.02% | |
| 20 DMA Support | Bullish | -3.28% | |
| Wide Bands | Range Expansion | -3.28% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 22 hours ago |
| Down 1% | about 22 hours ago |
| 50 DMA Resistance | about 22 hours ago |
| Rose Above Previous Day's High | about 23 hours ago |
| Rose Above 50 DMA | about 23 hours ago |
Get a Trading Sidekick!
- Earnings date: 09/09/2024
Avid Bioservices, Inc. Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Antibodies Monoclonal Antibodies Monoclonal Antibody
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.48 |
| 52 Week Low | 4.0705 |
| Average Volume | 864,266 |
| 200-Day Moving Average | 8.20 |
| 50-Day Moving Average | 10.66 |
| 20-Day Moving Average | 11.04 |
| 10-Day Moving Average | 11.03 |
| Average True Range | 0.60 |
| RSI (14) | 47.92 |
| ADX | 19.15 |
| +DI | 21.03 |
| -DI | 22.42 |
| Chandelier Exit (Long, 3 ATRs) | 10.68 |
| Chandelier Exit (Short, 3 ATRs) | 10.54 |
| Upper Bollinger Bands | 12.37 |
| Lower Bollinger Band | 9.72 |
| Percent B (%b) | 0.34 |
| BandWidth | 23.95 |
| MACD Line | 0.12 |
| MACD Signal Line | 0.23 |
| MACD Histogram | -0.1147 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 11.46 | ||||
| Resistance 3 (R3) | 11.47 | 11.22 | 11.32 | ||
| Resistance 2 (R2) | 11.22 | 11.01 | 11.21 | 11.27 | |
| Resistance 1 (R1) | 10.92 | 10.88 | 10.80 | 10.91 | 11.23 |
| Pivot Point | 10.67 | 10.67 | 10.60 | 10.66 | 10.67 |
| Support 1 (S1) | 10.37 | 10.46 | 10.25 | 10.36 | 10.03 |
| Support 2 (S2) | 10.12 | 10.33 | 10.11 | 9.99 | |
| Support 3 (S3) | 9.82 | 10.12 | 9.94 | ||
| Support 4 (S4) | 9.81 |
